Showing 3,401 - 3,420 results of 3,907 for search '"Ophthalmology"', query time: 0.06s Refine Results
  1. 3401

    Insights and Considerations for “Higher Intraocular Levels of Inflammatory Factors Are Related to Retinal Vascular and Neurodegeneration in Myopic Retinopathy” [Respons... by Zeng L, Yang Z, Li X, Xu H

    Published 2025-02-01
    “…Ling Zeng,1–3 Zhikuan Yang,1–3 Xiaoning Li,1–3 Heping Xu1–5 1Aier Academy of Ophthalmology, Central South University, Changsha, People’s Republic of China; 2Changsha Aier Eye Hospital, Changsha, People’s Republic of China; 3Aier Institute of Optometry and Vision Science, Aier Eye Hospital Group, Changsha, People’s Republic of China; 4Aier Eye Institute, Aier Eye Hospital Group, Changsha, People’s Republic of China; 5The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, BT9 7BL, UKCorrespondence: Heping Xu, Email heping.xu@qub.ac.uk Xiaoning Li, Email lixiaoning@aierchina.com…”
    Get full text
    Article
  2. 3402
  3. 3403
  4. 3404
  5. 3405
  6. 3406
  7. 3407
  8. 3408

    Prevalence, risk factors and associated ocular diseases of cerebral stroke: the population-based Beijing Eye Study by Jost B Jonas, Ya Xing Wang, Liang Xu, Wen Bin Wei

    Published 2020-09-01
    “…Objective To assess the prevalence of cerebral stroke in the general population of Beijing and its association with systemic risk factors and ocular diseases.Setting The population-based Beijing Eye Study was conducted in a rural and urban region of Beijing.Participants With eligibility criteria of age 50+ years and living in the study regions, 3468 subjects (78.8%) out of 4403 eligible individuals participated.Primary and secondary outcome measures The study participants underwent a detailed systemic and ophthalmological examination and an interview in which the occurrence of a previous stroke was assessed.Results A previous stroke was reported by 235 individuals (7.33%; 95% CI 6.43% to 8.24%). …”
    Get full text
    Article
  9. 3409
  10. 3410
  11. 3411
  12. 3412
  13. 3413
  14. 3414
  15. 3415
  16. 3416
  17. 3417

    Alopecia as the first manifestation of azathioprine myelosuppression in a genetically predisposed patient by Debashish Mishra, Shefali Khanna Sharma, Aman Sharma, Sanjay Jain, Varun Dhir

    Published 2019-01-01
    “…Azathioprine, an analog of mercaptopurine, is used for various inflammatory/autoimmune diseases in diverse fields such as rheumatology, ophthalmology, gastroenterology, and neurology. One of the dreaded side effects of this drug is myelosuppression, which can be either dose related or “idiosyncratic.” …”
    Get full text
    Article
  18. 3418
  19. 3419
  20. 3420